Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 52,021,696
  • Shares Outstanding, K 1,431,921
  • Annual Sales, $ 10,735 M
  • Annual Income, $ 4,700 M
  • 60-Month Beta 0.87
  • Price/Sales 5.07
  • Price/Cash Flow 15.04
  • Price/Book 3.34
Trade BSX with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 0.31
  • Number of Estimates 11
  • High Estimate 0.37
  • Low Estimate 0.26
  • Prior Year 0.46
  • Growth Rate Est. (year over year) -32.61%

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.16 +6.18%
on 12/21/20
37.04 -2.08%
on 01/08/21
+0.82 (+2.31%)
since 12/18/20
3-Month
32.99 +9.94%
on 11/23/20
39.50 -8.18%
on 11/09/20
-1.50 (-3.97%)
since 10/19/20
52-Week
24.10 +50.50%
on 03/23/20
44.44 -18.38%
on 01/22/20
-8.01 (-18.09%)
since 01/17/20

Most Recent Stories

More News
FILING DEADLINE--Kuznicki Law PLLC Announces Class Actions on Behalf of Shareholders of BSX and SPLK

The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of the following publicly traded companies.

BSX : 36.27 (-0.17%)
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SPLK, BSX and KNDI

NEW YORK, NY / ACCESSWIRE / January 19, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate...

SPLK : 172.96 (+1.76%)
BSX : 36.27 (-0.17%)
KNDI : 8.18 (+3.41%)
LAWSUITS FILED AGAINST BSX, NERV and SWI - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / January 19, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who...

BSX : 36.27 (-0.17%)
NERV : 3.45 (+27.31%)
SWI : 15.85 (-1.00%)
CLASS ACTION UPDATE for PINS, BSX and DECN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders

NEW YORK, NY / ACCESSWIRE / January 19, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders...

PINS : 71.01 (+1.81%)
BSX : 36.27 (-0.17%)
DECN : 0.0102 (-15.00%)
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BSX, QS, SPLK, SWI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the following securities class action lawsuits:

BSX : 36.27 (-0.17%)
LAWSUITS FILED AGAINST BRY, BSX and QIWI - Jakubowitz Law Pursues Shareholders Claims

NEW YORK, NY / ACCESSWIRE / January 18, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who...

BRY : 4.71 (unch)
BSX : 36.27 (-0.17%)
QIWI : 10.57 (+2.92%)
SHAREHOLDER ALERT: BSX NERV KNDI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / January 17, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a...

BSX : 36.27 (-0.17%)
NERV : 3.45 (+27.31%)
KNDI : 8.18 (+3.41%)
SHAREHOLDER ALERT: CLAIMSFILER REMINDS BSX, QS, SPLK, SWI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

ClaimsFiler, a FREE shareholder information service, reminds investors of pending deadlines in the following securities class action lawsuits:

BSX : 36.27 (-0.17%)
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of YY, PINS and BSX

NEW YORK, NY / ACCESSWIRE / January 15, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies....

YY : 91.77 (+1.88%)
PINS : 71.01 (+1.81%)
BSX : 36.27 (-0.17%)
BSX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 2, 2021 in the Class Action Filed on Behalf of Boston Scientific Corporation Limited Shareholders

New York, New York--(Newsfile Corp. - January 15, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Boston Scientific Corporation (NYSE: BSX)...

BSX : 36.27 (-0.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce...

See More

Key Turning Points

3rd Resistance Point 37.75
2nd Resistance Point 37.32
1st Resistance Point 36.79
Last Price 36.27
1st Support Level 35.84
2nd Support Level 35.41
3rd Support Level 34.89

See More

52-Week High 44.44
Fibonacci 61.8% 36.67
Last Price 36.27
Fibonacci 50% 34.27
Fibonacci 38.2% 31.87
52-Week Low 24.10

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar